tirzepatide and duloxetine demonstrates cardiovascular protection in head-to-head trial with dulaglutide tirzepatide and cymbalta What labs

Ling, Q., Huang, W

The co-primary endpoints were the percentage change of weight reduction in the Tirzepatide 10mg and 15mg dose groups at week 72 and the percentage of participants achieving 5% body weight reduction at 72 weeks compared to placebo

Dizziness reflects metabolic changes tirzepatide triggersprimarily blood sugar regulation and appetite suppressionbut it's not a required sign of effectiveness

Powell, J

Important Safety Information: Common side effects may include nausea, vomiting, diarrhea, decreased appetite, constipation, stomach pain, and injection site reactions

It works on two receptors simultaneously, GLP-1 and GIP (glucose-dependent insulinotropic polypeptide), which gives it a dual-action effect